Cardiovascular Disease Doctors in Searcy, AR Accepting Medicare

6 Cardiovascular Disease doctors found. Showing 1 - 6

John C Henderson, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2900 Hawkins Dr, Searcy, AR 72143 Phone: 501-278-2808    Fax: 501-278-3001

David Mark Evans, M. D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 711 Santa Fe Dr, Searcy, AR 72143 Phone: 501-279-9393

Katherine J Durham, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 711 Santa Fe Dr, Searcy, AR 72143 Phone: 501-279-9393

Ethan Munzinger, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 711 Santa Fe Dr, Searcy, AR 72143 Phone: 501-279-9393    Fax: 501-279-9073

Dr. Leon Roby Blue, M.D. Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 711 Santa Fe Dr, Searcy, AR 72143 Phone: 501-279-9393

Mrs. Katherine Elaine Shourd, APN Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 711 Santa Fe Dr, Searcy, AR 72143 Phone: 501-279-9393    Fax: 501-279-9073

News Archive

Researchers investigate whole-genome data to uncover new mutations for CAD risk

The Coronary ARtery DIsease Genome-wide Replication And Meta-Analysis (CARDIoGRAM) published in Circulation Cardiovascular Genetics, an American Heart Association journal consists of data from every published whole-genome study on genetic mutations in heart attack or CAD risk. Researchers are also pooling data from several unpublished genome-wide association studies to see if any new mutations can be uncovered.

Guerbet: FDA approves manufacturing plant for Lipiodol (ethiodized oil) Injection

Guerbet (GBT), the contrast agent specialist for medical imaging, today announced that it had received approval from the U.S. Food and Drug Administration (FDA) for a new manufacturing plant for Lipiodol® (ethiodized oil) Injection, in Montreal, Canada.

Possible molecular link between circadian rhythm disturbances and increased inflammatory response

Scientists have known for some time that throwing off the body's circadian rhythm can negatively affect body chemistry. In fact, workers whose sleep-wake cycles are disrupted by night shifts are more susceptible to chronic inflammatory diseases such as diabetes, obesity and cancer.

New stem-cell based therapy provides pain relief, reduces severity of RDEB in children

Promising results from a trial of a new stem-cell based therapy for a rare and debilitating skin condition have been published in the Journal of Investigative Dermatology. The therapy, involving infusions of stem cells, was found to provide pain relief and to reduce the severity of this skin condition for which no cure currently exists.

Read more Medical News

› Verified 4 days ago